• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4619888)   Today's Articles (1580)   Subscriber (49404)
For: Prado JC, Ruilope LM, Segura J. [Benefits of spironolactone as the optimal treatment for drug resistant hypertension. Pathway-2 trial review]. Hipertens Riesgo Vasc 2016;33:150-154. [PMID: 27363610 DOI: 10.1016/j.hipert.2016.05.003] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/01/2016] [Revised: 04/25/2016] [Accepted: 05/27/2016] [Indexed: 11/25/2022]
Number Cited by Other Article(s)
1
Ukrainets IV, Sidorenko LV, Golik MY, Chernenok IM, Grinevich LA, Davidenko AA. N-Aryl-7-hydroxy-5-oxo-2,3-dihydro-1H,5H-pyrido-[3,2,1-ij]quinoline-6-carboxamides. The Synthesis and Effects on Urinary Output. Sci Pharm 2018;86:E12. [PMID: 29642551 PMCID: PMC6027687 DOI: 10.3390/scipharm86020012] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/31/2018] [Revised: 03/27/2018] [Accepted: 02/04/2018] [Indexed: 12/11/2022]  Open
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA